annual current assets:
$3.23B+$276.34M(+9.35%)Summary
- As of today (June 23, 2025), BMRN annual total current assets is $3.23 billion, with the most recent change of +$276.34 million (+9.35%) on December 31, 2024.
- During the last 3 years, BMRN annual current assets has risen by +$958.04 million (+42.12%).
- BMRN annual current assets is now at all-time high.
Performance
BMRN Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$3.47B+$235.48M(+7.28%)Summary
- As of today (June 23, 2025), BMRN quarterly total current assets is $3.47 billion, with the most recent change of +$235.48 million (+7.28%) on March 31, 2025.
- Over the past year, BMRN quarterly current assets has increased by +$482.89 million (+16.18%).
- BMRN quarterly current assets is now at all-time high.
Performance
BMRN quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
BMRN Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +16.2% |
| 3 y3 years | +42.1% | +44.9% |
| 5 y5 years | +66.4% | +63.9% |
BMRN Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.1% | at high | +44.9% |
| 5 y | 5-year | at high | +66.4% | at high | +63.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
BMRN Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.47B(+7.3%) |
| Dec 2024 | $3.76B(-3.3%) | $3.23B(+5.8%) |
| Sep 2024 | - | $3.06B(-6.2%) |
| Jun 2024 | - | $3.26B(+9.2%) |
| Mar 2024 | - | $2.99B(+1.0%) |
| Dec 2023 | $3.89B(+7.2%) | $2.96B(+0.0%) |
| Sep 2023 | - | $2.96B(+0.2%) |
| Jun 2023 | - | $2.95B(+3.8%) |
| Mar 2023 | - | $2.84B(+3.3%) |
| Dec 2022 | $3.62B(-2.9%) | $2.75B(+2.6%) |
| Sep 2022 | - | $2.68B(+6.6%) |
| Jun 2022 | - | $2.52B(+5.2%) |
| Mar 2022 | - | $2.39B(+5.3%) |
| Dec 2021 | $3.73B(+6.4%) | $2.27B(-1.6%) |
| Sep 2021 | - | $2.31B(-2.0%) |
| Jun 2021 | - | $2.36B(+3.0%) |
| Mar 2021 | - | $2.29B(-2.3%) |
| Dec 2020 | $3.51B(+27.6%) | $2.34B(-14.5%) |
| Sep 2020 | - | $2.74B(+3.5%) |
| Jun 2020 | - | $2.65B(+25.1%) |
| Mar 2020 | - | $2.12B(+9.0%) |
| Dec 2019 | $2.75B(+15.9%) | $1.94B(+4.5%) |
| Sep 2019 | - | $1.86B(+2.9%) |
| Jun 2019 | - | $1.81B(-5.7%) |
| Mar 2019 | - | $1.92B(-6.8%) |
| Dec 2018 | $2.37B(-2.3%) | $2.06B(-14.6%) |
| Sep 2018 | - | $2.41B(+5.6%) |
| Jun 2018 | - | $2.28B(+1.7%) |
| Mar 2018 | - | $2.24B(+1.5%) |
| Dec 2017 | $2.43B(-6.8%) | $2.21B(+7.7%) |
| Sep 2017 | - | $2.05B(+40.5%) |
| Jun 2017 | - | $1.46B(+7.8%) |
| Mar 2017 | - | $1.35B(-4.9%) |
| Dec 2016 | $2.60B(-1.4%) | $1.42B(-14.7%) |
| Sep 2016 | - | $1.67B(+50.7%) |
| Jun 2016 | - | $1.11B(+11.4%) |
| Mar 2016 | - | $992.79M(-8.9%) |
| Dec 2015 | $2.64B(+144.9%) | $1.09B(-7.3%) |
| Sep 2015 | - | $1.18B(-3.2%) |
| Jun 2015 | - | $1.21B(-20.3%) |
| Mar 2015 | - | $1.52B(+8.9%) |
| Dec 2014 | $1.08B(-2.6%) | $1.40B(+29.7%) |
| Sep 2014 | - | $1.08B(-11.7%) |
| Jun 2014 | - | $1.22B(-2.1%) |
| Mar 2014 | - | $1.25B(+9.6%) |
| Dec 2013 | $1.11B(+34.2%) | $1.14B(+59.4%) |
| Sep 2013 | - | $713.48M(-1.0%) |
| Jun 2013 | - | $720.92M(-0.3%) |
| Mar 2013 | - | $723.02M(-2.7%) |
| Dec 2012 | $824.92M(-1.3%) | $743.43M(+3.3%) |
| Sep 2012 | - | $719.39M(+5.6%) |
| Jun 2012 | - | $681.53M(+32.8%) |
| Mar 2012 | - | $513.39M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $835.91M(+10.2%) | $469.80M(-3.5%) |
| Sep 2011 | - | $487.02M(-5.3%) |
| Jun 2011 | - | $514.11M(+2.0%) |
| Mar 2011 | - | $503.83M(-0.1%) |
| Dec 2010 | $758.36M(+68.7%) | $504.26M(-9.0%) |
| Sep 2010 | - | $554.19M(+6.2%) |
| Jun 2010 | - | $521.91M(+4.3%) |
| Mar 2010 | - | $500.43M(+7.0%) |
| Dec 2009 | $449.44M(+165.9%) | $467.73M(-10.1%) |
| Sep 2009 | - | $520.27M(+2.6%) |
| Jun 2009 | - | $506.98M(-29.0%) |
| Mar 2009 | - | $713.58M(-3.3%) |
| Dec 2008 | $169.00M(-1.2%) | $737.70M(+5.8%) |
| Sep 2008 | - | $697.01M(-0.7%) |
| Jun 2008 | - | $701.81M(+2.6%) |
| Mar 2008 | - | $683.73M(+6.1%) |
| Dec 2007 | $170.98M(+32.3%) | $644.30M(+0.5%) |
| Sep 2007 | - | $641.23M(+0.0%) |
| Jun 2007 | - | $640.93M(+99.9%) |
| Mar 2007 | - | $320.64M(-4.1%) |
| Dec 2006 | $129.21M(+2.3%) | $334.22M(-1.5%) |
| Sep 2006 | - | $339.37M(-1.6%) |
| Jun 2006 | - | $344.81M(-9.0%) |
| Mar 2006 | - | $378.76M(+449.4%) |
| Dec 2005 | $126.36M(-14.5%) | $68.94M(-16.1%) |
| Sep 2005 | - | $82.19M(+108.9%) |
| Jun 2005 | - | $39.34M(-26.6%) |
| Mar 2005 | - | $53.60M(-37.1%) |
| Dec 2004 | $147.81M(+375.7%) | $85.16M(-39.5%) |
| Sep 2004 | - | $140.69M(-22.5%) |
| Jun 2004 | - | $181.59M(-13.0%) |
| Mar 2004 | - | $208.82M(-7.3%) |
| Dec 2003 | $31.07M(+5.2%) | $225.27M(-11.4%) |
| Sep 2003 | - | $254.21M(-7.6%) |
| Jun 2003 | - | $275.05M(+77.7%) |
| Mar 2003 | - | $154.79M(+90.9%) |
| Dec 2002 | $29.54M(-15.7%) | $81.07M(-11.3%) |
| Sep 2002 | - | $91.37M(-13.4%) |
| Jun 2002 | - | $105.56M(-14.5%) |
| Mar 2002 | - | $123.43M(-9.8%) |
| Dec 2001 | $35.03M(+8.1%) | $136.78M(+170.1%) |
| Sep 2001 | - | $50.64M(-20.4%) |
| Jun 2001 | - | $63.59M(+77.3%) |
| Mar 2001 | - | $35.86M(-19.5%) |
| Dec 2000 | $32.39M(-12.8%) | $44.54M(-13.4%) |
| Sep 2000 | - | $51.41M(-4.0%) |
| Jun 2000 | - | $53.53M(-13.0%) |
| Mar 2000 | - | $61.55M(-7.3%) |
| Dec 1999 | $37.13M(+98.4%) | $66.42M(-13.1%) |
| Sep 1999 | - | $76.40M(+262.1%) |
| Jun 1999 | - | $21.10M(+283.6%) |
| Mar 1999 | - | $5.50M |
| Dec 1998 | $18.71M | - |
FAQ
- What is BioMarin Pharmaceutical annual total current assets?
- What is the all time high annual current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual current assets year-on-year change?
- What is BioMarin Pharmaceutical quarterly total current assets?
- What is the all time high quarterly current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly current assets year-on-year change?
What is BioMarin Pharmaceutical annual total current assets?
The current annual current assets of BMRN is $3.23B
What is the all time high annual current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total current assets is $3.23B
What is BioMarin Pharmaceutical annual current assets year-on-year change?
Over the past year, BMRN annual total current assets has changed by +$276.34M (+9.35%)
What is BioMarin Pharmaceutical quarterly total current assets?
The current quarterly current assets of BMRN is $3.47B
What is the all time high quarterly current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total current assets is $3.47B
What is BioMarin Pharmaceutical quarterly current assets year-on-year change?
Over the past year, BMRN quarterly total current assets has changed by +$482.89M (+16.18%)